Navigation Links
Spherix Announces Third Quarter Financial Results
Date:11/11/2011

BETHESDA, Md., Nov. 11, 2011 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today reported financial results for the three and nine months ended September 30, 2011.

Recent and Upcoming Highlights

  • Pharmaceutical Development
  • Reported that SPX-106T, a combination of SPX-106 with D-tagatose, reduced dyslipidemia in new studies of apolipoprotein E-deficient mice and Syrian Golden hamsters, which also corroborated data obtained in LDL receptor-deficient mice
  • Reported that a new study in rats demonstrated that D-tagatose inhibits fructose absorption in the gastrointestinal tract, and this finding provides further insight into the mechanism of action of SPX-106T
  • Reported that SPX-106T reduced VLDL and LDL in LDL receptor-deficient mice, as well as atherosclerotic lesion area in the aortic arch to less than one-half the value of the untreated group
  • Continued research contracts to investigate the role of D-tagatose in lowering triglycerides
  • Continued preclinical testing of SPX106T for treatment of high triglycerides and cholesterol, atherosclerosis and the metabolic syndrome

  • Health Sciences Consulting
  • Recent and upcoming trade and professional shows:
  • August 17, 2011: Dr. Kruger presented "Regulatory Pathways to Market: A Discussion of Dietary Supplements, Medical Food, and Nutraceuticals," at the Pharmaceutical Education & Research Institute, Inc. (PERI)'s Webinar
  • August 2011 publication: Kruger, C.L., Booth, N. and Hayes, A.W., "Policing Ourselves: Is GRAS Robust Enough?," Food Technology, pages 18-19
  • September 8, 2011:  Spherix Consulting pre
    '/>"/>

  • SOURCE Spherix Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds
    2. Spherix to Raise $1.25 Million in Private Placement
    3. Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight
    4. Spherix Announces Annual Shareholders Meeting Date
    5. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
    6. Spherix Regains Compliance With NASDAQ Listing Rule
    7. Spherix Announces First Quarter Financial Results
    8. Spherix Announces Reverse Stock Split Effective May 6, 2011
    9. Spherix to Effect Reverse Stock Split
    10. Spherix Announces 2010 Financial Results
    11. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... OR (PRWEB) October 20, 2014 Local ... participate in an investigational study of donor stem cells ... in stem cell therapy and has performed clinical stem ... this study is to determine if a single injection ... affected joints can help reduce pain and inflammation in ...
    (Date:10/19/2014)... 19, 2014 The Asia-Pacific Bromine ... in Asia-Pacific with analysis and forecast of revenue. ... Pacific Bromine Market report, to get an idea ... a glimpse of the segmentation in the Asia-Pacific ... and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , ...
    (Date:10/19/2014)... Orthopedic braces and support systems report defines and segments the ... The Orthopedic braces and support systems market in Asia is ... a developing CAGR of 4.4% from 2013 to 2018. , ... support systems market, to get an idea of the in-depth ... of orthopedic braces and support systems market in the same ...
    (Date:10/18/2014)... October 18, 2014 The Asia-Pacific ... and segments the bio-based advanced phase change material ... revenue. , Browse through the TOC of the ... to get an idea of the in-depth analysis ... segmentation in the Asia-Pacific bio-based advanced phase change ...
    Breaking Biology Technology:Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 4
    ... 5 Schering-Plough Corporation (NYSE: SGP ) ... by David Nicholson, Ph.D., senior vice president, Global Project ... Barclays Capital Global Healthcare Conference in Miami on Tuesday, ... is expected to talk about the company,s R&D pipeline ...
    ... rosacea-specific study also slated for presentation at American Academy ... NAPA, Calif., March 5 Senetek PLC (OTC Bulletin ... development of technologies that target the science of healthy ... at the American Academy of Dermatology,s 67th Annual Meeting ...
    ... SAN FRANCISCO, Calif., March 5 Poniard Pharmaceuticals, ... company focused on innovative oncology therapies, today announced ... discuss the Company,s fourth quarter and year-end financial ... development activities for picoplatin, the Company,s lead product ...
    Cached Biology Technology:Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers 2Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers 3Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12 2
    (Date:10/18/2014)... referred for evaluation of suspected genetic conditions, whole-exome ... percent, including detection of a number of rare ... according to a study appearing in JAMA ... with the American Society of Human Genetics annual ... coding regions of thousands of genes simultaneously using ...
    (Date:10/17/2014)... German . To ... treating overdoses, doctors are often limited to supportive therapy such ... a combination of drugs involved. So what can be done ... pills? ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical ... this question. "The task was to develop an agent that ...
    (Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
    Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
    ... a person with allergies or asthma, breathing in pollen ... inhalation by someone sensitive to their effects, these tiny ... producing uncontrollable sneezing, coughing, or extreme shortness of breath ... allergy and asthma attacks. , Scientists have long assumed ...
    ... of the effect of male circumcision on HIV infection, ... published in PLoS Medicine on October 25. ... new infections among heterosexual men in South Africa by ... are generally lower among African groups where circumcision is ...
    ... Nuclear Medicine uses PET, radiotracer to track enzyme in ... enzyme in the lungs, possibly contributing to some of ... in the September issue of the Journal of Nuclear ... the enzyme, also shows that smokers had a lower ...
    Cached Biology News:New factor implicated in allergy and asthma attacks 2New factor implicated in allergy and asthma attacks 3PLoS Medicine publishes first trial of effect of male circumcision on HIV infection 2PLoS Medicine publishes first trial of effect of male circumcision on HIV infection 3Smoking damages key regulatory enzyme in the lung 2Smoking damages key regulatory enzyme in the lung 3